These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10837886)

  • 1. The prolactin response to buspirone in poststroke depression: a preliminary report.
    Sevinçok L; Erol A
    J Affect Disord; 2000 Aug; 59(2):169-73. PubMed ID: 10837886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin response to buspirone is not impaired in drug-naïve first episode patients with major depressive disorder.
    Cubała WJ; Landowski J
    J Affect Disord; 2014 Jan; 152-154():468-73. PubMed ID: 24035672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal response to buspirone is not impaired in major depression.
    Navinés R; Gómez-Gil E; Martín-Santos R; de Osaba MJ; Escolar G; Gastó C
    Hum Psychopharmacol; 2007 Aug; 22(6):389-95. PubMed ID: 17563921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects.
    Meltzer HY; Maes M
    Biol Psychiatry; 1994 Mar; 35(5):316-23. PubMed ID: 8011800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunted prolactin response to D-fenfluramine in post-stroke major depression.
    Morris P; Hopwood M; Maguire K; Norman T; Schweitzer I
    J Affect Disord; 2003 Sep; 76(1-3):273-8. PubMed ID: 12943959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buspirone/prolactin response in post head injury depression.
    Mobayed M; Dinan TG
    J Affect Disord; 1990 Aug; 19(4):237-41. PubMed ID: 2146299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neuroendocrine study of serotonin function in depressed stroke patients compared to non depressed stroke patients and healthy controls.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    J Affect Disord; 1999; 52(1-3):121-33. PubMed ID: 10357025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary study of buspirone stimulated prolactin release in generalised social phobia: evidence for enhanced serotonergic responsivity?
    Condren RM; Dinan TG; Thakore JH
    Eur Neuropsychopharmacol; 2002 Aug; 12(4):349-54. PubMed ID: 12126875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central 5-HT receptor hypersensitivity in migraine without aura.
    Cassidy EM; Tomkins E; Dinan T; Hardiman O; O'Keane V
    Cephalalgia; 2003 Feb; 23(1):29-34. PubMed ID: 12534577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary neuroendocrine study with buspirone in major depression.
    Moeller FG; Steinberg JL; Fulton M; Kramer G; Petty F
    Neuropsychopharmacology; 1994 Apr; 10(2):75-83. PubMed ID: 8024675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poststroke depression and its multifactorial nature: results from a prospective longitudinal study.
    De Ryck A; Fransen E; Brouns R; Geurden M; Peij D; Mariën P; De Deyn PP; Engelborghs S
    J Neurol Sci; 2014 Dec; 347(1-2):159-66. PubMed ID: 25451004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative validity of depression assessment scales for screening poststroke depression.
    Kang HJ; Stewart R; Kim JM; Jang JE; Kim SY; Bae KY; Kim SW; Shin IS; Park MS; Cho KH; Yoon JS
    J Affect Disord; 2013 May; 147(1-3):186-91. PubMed ID: 23167974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reappraisal of poststroke depression, intra- and inter-hemispheric lesion location using meta-analysis.
    Narushima K; Kosier JT; Robinson RG
    J Neuropsychiatry Clin Neurosci; 2003; 15(4):422-30. PubMed ID: 14627768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poststroke fatigue: risk factors and its effect on functional status and health-related quality of life.
    Chen YK; Qu JF; Xiao WM; Li WY; Weng HY; Li W; Liu YL; Luo GP; Fang XW; Ungvari GS; Xiang YT
    Int J Stroke; 2015 Jun; 10(4):506-12. PubMed ID: 25472471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dyskinesia predicts prolactin response to buspirone challenge in people with schizophrenia.
    Shim JC; Kim YH; Kelly DL; Lee JG; Conley RR
    J Neuropsychiatry Clin Neurosci; 2005; 17(2):221-6. PubMed ID: 15939977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is poststroke depression a major depression?
    da Rocha e Silva CE; Alves Brasil MA; Matos do Nascimento E; de Bragança Pereira B; André C
    Cerebrovasc Dis; 2013; 35(4):385-91. PubMed ID: 23635428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buspirone induced prolactin responses in obsessive-compulsive disorder (OCD): is OCD a 5-HT2 receptor disorder?
    Lucey JV; Butcher G; Clare AW; Dinan TG
    Int Clin Psychopharmacol; 1992; 7(1):45-9. PubMed ID: 1624756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin response to buspirone was reduced in violent compared to nonviolent parolees.
    Cherek DR; Moeller FG; Khan-Dawood F; Swann A; Lane SD
    Psychopharmacology (Berl); 1999 Feb; 142(2):144-8. PubMed ID: 10102766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone.
    Cassidy EM; Tomkins E; Sharifi N; Dinan T; Hardiman O; O'Keane V
    Pain; 2003 Feb; 101(3):283-290. PubMed ID: 12583871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression in premenopausal women: gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test.
    Rajewska J; Rybakowski JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):705-9. PubMed ID: 12787860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.